Defective release of eosinophil chemotactic factor from peripheral leukocytes in patients with chronic urticaria.

In vitro release of eosinophil chemotactic factor of anaphylaxis (ECF-A) from guinea pig skin.

Cold urticaria as a model of mediator release: platelet factor 4, eosinophil cationic protein and histamine.

Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis.

The mediation of tissue eosinophilia in hypersensitivity reactions. II. Separation of a delayed eosinophil chemotactic factor from macrophage chemotactic factors.

Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).

Chemotactic activities of peripheral blood polymorphonuclear leukocytes and peritoneal exudate polymorphonuclear leukocytes in MRL mice.

Increased eosinophil chemotactic activity in bronchial washes obtained from patients with asymptomatic allergic alveolitis.

Chemotactic response of leukocytes to cord factor (trehalose-6,6'-dimycolate).

Thyroid Autoimmunity in Patients with Chronic Urticaria.

Staining of eosinophil granulocytes in chemotactic studies.

Eosinophil purification from peripheral blood.

The selective eosinophil chemotactic activity of histamine.

Chemotactic factor-induced release of membrane calcium in rabbit neutrophils.

Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human polymorphonuclear leucocytes (PMN).

Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.

Antibodies directed to the chemotactic factor receptor detect differences between chemotactically normal and defective neutrophils from LJP patients.

The effect of enzyme digestions on the activity of eosinophil chemotactic factor of anaphylaxis (EFC-A).

Sensory adaptation of leukocytes to chemotactic peptides.

Staining of rabbit eosinophil and pseudoeosinophil leukocytes.

Platelet and other hemostatic characteristics in patients with chronic urticaria.

Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease.

Basophil activation test with food additives in chronic urticaria patients.

Sense of coherence as a protective factor in chronic urticaria.

[Inhibitory activity of mite IgG4, antibody on antigen-induced histamine release from human peripheral blood leukocytes].

Suggest Documents

In vitro release of eosinophil chemotactic factor of anaphylaxis (ECF-A) from guinea pig skin.

Cold urticaria as a model of mediator release: platelet factor 4, eosinophil cationic protein and histamine.

Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis.

The mediation of tissue eosinophilia in hypersensitivity reactions. II. Separation of a delayed eosinophil chemotactic factor from macrophage chemotactic factors.

Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).

Chemotactic activities of peripheral blood polymorphonuclear leukocytes and peritoneal exudate polymorphonuclear leukocytes in MRL mice.

Increased eosinophil chemotactic activity in bronchial washes obtained from patients with asymptomatic allergic alveolitis.

Chemotactic response of leukocytes to cord factor (trehalose-6,6'-dimycolate).

Thyroid Autoimmunity in Patients with Chronic Urticaria.

Staining of eosinophil granulocytes in chemotactic studies.

Eosinophil purification from peripheral blood.

The selective eosinophil chemotactic activity of histamine.

Chemotactic factor-induced release of membrane calcium in rabbit neutrophils.

Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human polymorphonuclear leucocytes (PMN).

Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.

Antibodies directed to the chemotactic factor receptor detect differences between chemotactically normal and defective neutrophils from LJP patients.

The effect of enzyme digestions on the activity of eosinophil chemotactic factor of anaphylaxis (EFC-A).

Sensory adaptation of leukocytes to chemotactic peptides.

Staining of rabbit eosinophil and pseudoeosinophil leukocytes.

Platelet and other hemostatic characteristics in patients with chronic urticaria.

Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease.

Basophil activation test with food additives in chronic urticaria patients.

Sense of coherence as a protective factor in chronic urticaria.

[Inhibitory activity of mite IgG4, antibody on antigen-induced histamine release from human peripheral blood leukocytes].

Defective release of eosinophil chemotactic factor from peripheral leukocytes in patients with chronic urticaria.

Recommend Documents

Follow Us